1 A9-Tetrahydrocannabinol and cannabidiol both exhibited a concentration-related inhibition of Mg2+-ATPase of vesicles prepared from synaptosomes isolated from rat cerebral cortex. Cannabidiol was about 3 times more potent than tetrahydrocannabinol. 2 These results were similar to those obtained previously using drugs with well established anticonvulsant activity. 3 Tetrahydrocannabinol at a sub-inhibitory concentration (1 ,uM) increased the activity of the Mg2+-ATPase relative to values obtained with vehicle controls.
Introduction
The effects of a wide range of drugs on the activity of the magnesium-activated adenosine triphosphatase (Mg2+-ATPase) of synaptic vesicles prepared from rat cerebral cortex have previously been studied (Gilbert & Wyllie, 1975; ). Of the drugs tested only those known to have anticonvulsant activity were found to inhibit this ATPase. A9-Tetrahydrocannabinol (tetrahydrocannabinol) and cannabidiol, both constituents of cannabis, exhibit anticonvulsant activity in rats (Izquierdo, Orsingher & Berardi, 1973) and mice (Karler, Cely & Turkanis, 1973) and it was therefore of interest to investigate the effect of these cannabinoids on the activity of the vesicular Mg2+-ATPase.
Methods
Mitochondrial and synaptosomal fractions were prepared from cerebral cortices of male SpragueDawley rats (body wt. 150 to 350 g) by a modification of the method of Gray & Whittaker (1962) as described by Gilbert & Wyllie (1976) . Synaptic vesicles were prepared by osmotic disruption of synaptosomes and subsequent sucrose density gradient centrifugation as described by Whittaker, Michaelson & Kirkland (1964 The samples were pre-incubated for 15 min at 370C before the reactions were started by addition of 0.1 ml Tris-ATP solution (4 mm final concentration). Sodium dodecyl sulphate (DDS 1 ml, 0.8% w/v in water) was used to stop the reactions after 10 minutes. The phosphate contents of the clear solutions were determined by the method of Bonting, Simon & Hawkins (1961) . Blanks were prepared by addition of DDS after the pre-incubation period, before the addition of the ATP.
The activity of Mg2+-ATPase was calculated by subtraction of the phosphate released in the blank from that in the Mg2+-ATPase reaction mixture.
The protein contents of solutions were determined by the method of Lowry, Rosenbrough, Farr & Randall (1951 (Izquierdo et al., 1973; Karler et al., 1973) the results add to the evidence (Gilbert & Wyllie, 1976) for the concept that the capacity to inhibit the vesicular Mg2+-ATPase is a characteristic property of anticonvulsant drugs.
There are similarities between the effects of the cannabinoids reported in this paper and the effects (reported elsewhere, Gilbert & Wyllie, 1976 ) of other anticonvulsant drugs. The concentrations at which tetrahydrocannabinol and cannabidiol inhibited vesicular Mg2+-ATPase are of the same order as those at which other anticonvulsant drugs produce inhibition. As with the other anticonvulsants so far studied, the inhibition of vesicular Mg2+-ATPase produced by the cannabinoids at maximal concentrations was not complete. This incomplete inhibition may result from the heterogeneity of the nerve terminal content of the synaptosome preparation. This point has been discussed elsewhere (Gilbert & Wylie, 1976) .
A sub-inhibitory concentration of tetrahydrocannabinol was found to increase Mg2+-ATPase activity relative to values observed in the presence of ethanol, the vehicle in which the drug was dissolved. Further experiments are needed to determine whether this observation reflects direct activation of the enzyme by tetrahydrocannabinol or antagonism of the inhibitory effect of ethanol. In addition it would be interesting to determine whether, at sub-inhibitory concentrations, cannabidiol increases the activity of Mg2+-ATPase.
Finally, it is of interest that the relative potency of tetrahydrocannabinol and cannabidiol in inhibiting vesicular Mg2+-ATPase is of about the same value as the relative potency of these cannabinoids in decreasing the susceptibility of rat hippocampus to seizure discharges caused by afferent stimulation (Izquierdo et al., 1973) . However, without further experimental data it would not be profitable to speculate about this correlation which could well have arisen by chance and the question of whether there is a 'cause-effect' relationship between the inhibition of vesicular Mg2+-ATPase and anticonvulsant activity still remains to be answered. We thank Dr M.C. Braude of NIMH for supplies through the MRC of A9-tetrahydrocannabinol and Professor R.
Mechoulam for a gift of cannabidiol. Number of experiments are given in parentheses. Student's t test (paired) was used to evaluate (P) differences between drug treatment and ethanol controls. A typical value for vesicular Mg2+-ATPase activity (in the absence of ethanol) was 5.25 +0.17 (4) imol Pi mg protein-' h-1.
